SANOFI SYNTHELABO SA 13D/13G Filings for Fulcrum Therapeutics, Inc. (FULC)

SANOFI SYNTHELABO SA 13D and 13G filings for Fulcrum Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-11
10:46 am
Purchase		 2020-02-13 13G Fulcrum Therapeutics, Inc.
FULC		 SANOFI SYNTHELABO SA 3,363,050
4.600%		 3,363,050increase
(New Position)		 Filing